NEW YORK, July 29, 2015 /PRNewswire/ --
P&S Market Research releases a new research report "Global Industry Insight: Microfluidic Devices Market Development and Demand Forecast to 2020" with market overview, trends, DRO analysis, market segmentation, market size and forecast, porter analysis, recent developments, competitive scenario and top competitor profiles.
Microfluidic devices market is gaining significant importance due to growing R&D investment in life sciences, pharmaceuticals, and increasing point of care testing demand. The global market for microfluidic devices is expected to grow at a CAGR of 23.0% during the period 2015 to 2020 to reach $6,471 million by 2020. The factors driving the growth of microfluidic devices market are increase in demand for point of care testing products, rise in the commercial and analytical applications of these devices, and use of microfluidic products for miniaturization of chip.
Explore Report Description, TOC, Scope of Report of Global Microfluidic Devices Market: https://www.psmarketresearch.com/market-analysis/microfluidic-devices-market
Continuous innovations in microfluidic devices have led to transformation of drug discovery and development, gene expression analysis and genotyping in the pharmaceutical and biopharmaceutical industry. Microfluidic device companies are entering in collaborations and partnerships to build innovative approaches, offering advanced tools for diagnostics and research. But regulatory issues act as hindrance in the development of microfluidic devices market. Apart from regulatory challenges, the market also confronts issues from surface chemistry and geometrical problem during manufacturing process.
On the basis of application, point of care testing (POCT) is by far the fastest growing application area of microfluidic devices. The growth of application of microfluidic devices in POCT is expected to witness a CAGR of 28.2% during the period 2015 to 2020, to reach $1.8 billion in 2020. An increase in point of care testing, as an effective method for delivery of treatment, has also led to increase in demand for the microfluidic devices in the global market. Diagnostic companies are getting access to microfluidic based technologies through acquisitions, as it reduces the technology development risk and increases the reactivity.
Request for Report Sample of Global Microfluidic Devices Market: https://www.psmarketresearch.com/enquiry-form.php?enqid=211&title=Report%20sample
In terms of material, the polymer had the largest share in the global microfluidic devices market, and it is expected to grow at the highest CAGR among all the materials during the forecast period. Polymer is an attractive alternative to glass and silicon, as it has faster fabrication process and is comparatively cheaper. Polymer has also become the most preferred substrate for POCT applications, and has several advantages like oxygen permeability, gas permeability, nontoxic and optical transparency.
At present, North America dominates the global microfluidic devices market, driven by factors such as growing geriatric population, increasing health and wellness awareness, rising occurrence of chronic and lifestyle ailments, informed insurance options and various technological developments suited for varied applications. Asia-Pacific is expected to emerge as an attractive market for the companies manufacturing medical devices. In Europe, the microfluidic devices market is driven by increased diagnostic requirements, attributed to rising diseases and lifestyle changes, aging population and improving healthcare facilities. The European microfluidic devices market is expected to report the highest CAGR during 2015 to 2020 among all the regions; whereas, North America will remain the largest market in 2020.
Browse more reports on medical devices: https://www.psmarketresearch.com/industry-report/medical-devices
The major companies operating in the microfluidic devices market include Abbott Laboratories, Agilent Technologies, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc. Cepheid, Dolomite Centre, F. Hoffmann-La Roche, Fluidigm Corporation, Johnson & Johnson, Micronit Microfluidics, RainDance Technologies, Inc., and Siemens Healthcare, Inc.
Browse other reports:
Global Analgesic Infusion Pumps Market - https://www.psmarketresearch.com/market-analysis/analgesic-infusion-pumps-market
Obesity Surgery Devices Market - https://www.psmarketresearch.com/market-analysis/obesity-surgery-devices-market
Global Dermatology Devices Market - https://www.psmarketresearch.com/market-analysis/dermatology-devices-market
MICROFLUIDIC DEVICES MARKET SEGMENTATION
Global Microfluidic Devices Market Breakdown
- By Industry
- By Application
- By Material
- By Region
Microfluidic Devices Market Breakdown by Industry
- In-vitro Diagnostics (IVD)
- Medical Devices
Microfluidic Devices Market Breakdown by Application
- Point of Care Testing
- Pharmaceutical and Life Science Research
- Drug Delivery
- Analytical Devices
- Clinical and Veterinary Diagnostics
- Environmental and Industrial
Microfluidic Devices Market Breakdown by Material
Microfluidic Devices Market by Region
- North America
- The U.S.
- The U.K.
About P&S Market Research
P&S Market Research is a global market research and consulting company. We provide market research reports, industry reports, business intelligence and research based consulting services across a range of industries.
With the help of our professional corporate relations with various companies, our market research offers the most accurate market forecasting. Our analysts and consultants interact with leading companies of the concerned domain to substantiate every single data presented in our publication. Our research assists our client in identifying new and different windows of opportunity and frame informed and customized strategies for expansion in different regions.
Manager - Client Partner
347, 5th Ave. #1402
New York City, NY -10016
Toll-free: +1-888-778-7886 (USA/Canada)
SOURCE P&S Market Research